Advanced search
Publication Cover
Leukemia & Lymphoma Volume 18, 1995 - Issue 5-6
Submit an article Journal homepage
19
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Effects of Long-Term Treatment with Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndrome

Yataro Yoshida The 1st Department of Medicine, Kyoto University School of Medicine, Kyoto
,
Tatsutoshi Nakahata Department of Clinical Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo
,
Akira Shibata The Ist Department of Medicine, Niigata University School of Medicine, Niigata
,
Masuhiro Takahashi The Ist Department of Medicine, Niigata University School of Medicine, Niigata
,
Yoshiaki Moriyama The Ist Department of Medicine, Niigata University School of Medicine, Niigata
,
Kohei Kaku The 3rd Department of Medicine, Yamaguchi University School of Medicine, Ube
,
Toru Masaoka The 5th Internal Medicine, Center for Adult Disease, Osaka
,
Toshio Kaneko The 3rd Department of Medicine, Yamaguchi University School of Medicine, Ube
&
Shiro Miwa Okinaka Memorial Institute for Medical Research, Tokyo, Japan
 show all
Pages 457-463 | Received 09 Oct 1994, Published online: 01 Jul 2009

References

  • Yoshida Y. Japanese experience in the treatment of myelodysplastic syndromes. Hematol/Oncol Clin North America 1992; 6: 673–685
  • Griffin J.D., Spriggs D., Wisch J.S., Kufe W. Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside. J. Clin. Oncol. 1985; 3: 982–991
  • Metcalf D. The granulocyte-macrophage colony-stimulating factor. Science 1985; 229: 16–22
  • Vadhan-Raj S., Keating Le M., Maistre A., Hittelman W.N., McCredie K., Trujillo J.M., Broxmeyer H.E., Henney C., Gutterman J.U. Effects of recombinant human granulocyte-macrophage colony-stimulaitng factor in patients with myelodysplastic syndromes. N. Engl. J. Med. 1987; 317: 1545–1552
  • Takahashi M., Yoshida Y., Kaku K., Masaoka T., Moriyama Y., Nakanishi S., Kaneko T., Shibata A., Miwa S. A phase II study of recombinant human granulocyte-macrophage colony stimulating factor in myelodysplastic syndrome and aplastic anemia. Acta Haematol. 1993; 89: 189–194
  • Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnic H.R., Sultan C. Proposals for classification of the myelodysplasitc syndromes. Br. J. Haematol. 1982; 51: 189–199
  • Cantrell M.A., Anderson D., Cerretti D.P., Price V., Makereghan K., Tushuinski R.J., Mochizuki D.Y., Larsen A., Grabstein K., Gillis S., Cosman D. Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 1985; 82: 6250–6254
  • Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
  • Gamer A., Volkers B., Greher J., Ottmann O.G., Walther F., Becher R., Bergmann L., Schulz G., Hoelzer D. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes+ phase VII trial. Blood 1989; 73: 31–37
  • Thompson J.A., Lee D.J., Kidd P., Rubin E., Kaufmann J., Bonnem E.M., Fefer A. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects. J. Clin. Oncol. 1989; 7: 629–637
  • Resenfeld C.S., Sulecki M., Evans C., Shadduck R.K. Comparison of intravenous versus subcutaneous recombinant human granulocyte-macrophage colony-stimulating factor in patients with primary myelodysplasia. Exp. Hematol. 1991; 19: 213–277
  • Aul C., Gattermann N., Heyll A., Germing U., Derigs G., Schneider W. Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992; 6: 52–59
  • Negrin R.S., Haeuber D.H., Nagler A., Kobayashi Y., Sklar J., Donlon T., Vincent M., Greenberg P. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 1990; 76: 36–43
  • Verhoef G., Boogaerts M. In vivo administration of granulocyte-macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromes. Br. J. Haematol. 1991; 79: 117–184
  • Nimer S.D., Champlin R.E., Golde D.W. Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor. JAMA 1988; 260: 3297–3330
  • Takahashi M., Nikkuni K., Moriyama Y., Shibata A. GM-CSF-mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol. Am. J. Hematol. 1991; 36: 213–214
  • Link H., Boogaerts M.A., Carella A.M., et al. A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy. and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma. Blood 1992; 80: 2188–2195

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.